Amy Purrington
Janssen Pharmaceuticals, Inc.
Head, Signal Management Group
Amy is an experienced pharmacovigilance physician, focusing on proactive surveillance. She has been in industry for 15 years and at JNJ for the last 12. She is currently the lead of the Signal Management Group, which is dedicated to the development and implementation of new signal detection methods, tools, and data sources to advance the science of signal detection and surveillance. Amy has a BA from Cornell U, MD from U of Chicago, and is board certified in Internal Medicine.